首页> 外文期刊>American journal of medical genetics, Part A >Mortality of congenital osteochondrodysplasias: a nationwide registry-based study.
【24h】

Mortality of congenital osteochondrodysplasias: a nationwide registry-based study.

机译:先天性骨质升降术的死亡率:基于全国的注册表的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Osteochondrodysplasias are a heterogeneous group of more than 200 entities, characterized by abnormalities of cartilage, bone growth, and skeletal development. The aim of this study was to assess temporal and spatial changes in overall mortality due to these disorders in Spain, using data from a nationwide registry. Annual deaths showing osteochondrodysplasias as the underlying cause of death were selected using the International Classification of Diseases-9th revision (ICD-9) codes for the period 1981 through 1998, and ICD-10 codes for the period 1999 through 2008. Age-adjusted mortality rates were calculated by sex, and geographic analysis was performed by municipality. A total of 679 deaths were recorded (53% men). Age-adjusted mortality rates went from 0.09 (0.06, 0.12) per 100,000 population in 1981 to 0.05 (0.03, 0.08) per 100,000 population in 2008. A changing trend in the age-standardized mortality rate was in evidence, with an annual increase of 2.4% (-0.4, 5.2) from 1981 to 1994, and an annual decrease of -7.3% (-10.9, -3.5) from 1995 onwards. Geographic analysis showed some places situated in the west and south of Spain with greater risk of mortality. There is a need to identify risk factors and to increase overall knowledge about the life expectancy and epidemiology of osteochondrodysplasias.
机译:骨孔骨细胞增强是200多个实体的异质组,其特征在于软骨,骨骼生长和骨骼发育异常。本研究的目的是利用来自全国范围内注册管理机构的数据,评估由于西班牙的这些障碍而导致的整体死亡率的时间和空间变化。年终死亡,显示骨科重新划分为1981年至1998年至1998年至1998年至1998年至1998年至1998年至1998年的国际疾病第9次修订(ICD-9)代码的潜在原因,以及1999年至2008年期间的ICD-10代码。年龄调整后的死亡率利率是按性别计算的,并且由市政府进行地理分析。记录了679人死亡(53%的人)。年龄调整后的死亡率在2008年的1981年每10万人每10万人达到0.09(0.06,0.12),以每10万人口为0.05(0.03,0.08)。年龄标准化死亡率的变化趋势是证据,年增长率1981年至1994年的2.4%(-0.4,5.2),从1995年开始,年下降-7.3%(-10.9,-3.5)。地理分析显示,西班牙西部和西班牙南部的一些地方具有更大的死亡风险。有必要识别风险因素,并提高对骨质体细胞增强的预期寿命和流行病学的整体知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号